Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in TC BioPharm (Holdings) plc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

TCBP is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023

Institutional holders
12
+4 vs. Q3 2024
Shares held
54.9K
+45.6K (+489.3%) vs. Q3 2024
Total value
$34.8K
−$14.0K (−28.7%) vs. Q3 2024
New holders
8
2 more added
Sold out
4
0 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 12 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 8 institutionsQ2 2022: 5 institutionsQ3 2022: 5 institutionsQ4 2022: 2 institutionsQ1 2023: 4 institutionsQ2 2023: 6 institutionsQ3 2023: 12 institutionsQ4 2023: 4 institutionsQ1 2024: 5 institutionsQ2 2024: 8 institutionsQ3 2024: 8 institutionsQ4 2024: 12 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $34.8K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $399.0KQ2 2022: $166.0KQ3 2022: $141.0KQ4 2022: $323.8KQ1 2023: $207.3KQ2 2023: $380.1KQ3 2023: $179.6KQ4 2023: $243.8KQ1 2024: $42.6KQ2 2024: $77.0KQ3 2024: $48.9KQ4 2024: $34.8KQ1 2025: $34Q2 2025: $34Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCBP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$34
Q1 20251$34
Q4 202412$34.8K
Q3 20248$48.9K
Q2 20248$77.0K
Q1 20245$42.6K
Q4 20234$243.8K
Q3 202312$179.6K
Q2 20236$380.1K
Q1 20234$207.3K
Q4 20222$323.8K
Q3 20225$141.0K
Q2 20225$166.0K
Q1 20228$399.0K
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding TC BioPharm (Holdings) plc; share changes are against Q3 2024.

Institutions holding TCBP in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Cubist Systematic Strategies, LLC15,553$10.0K0.00%+15,553New
Virtu Financial LLC16,042$10.0K0.00%+16,042New
HRT Financial LP14,316$9.00K0.00%+14,316New
SBI Securities Co., Ltd.4,127$2.66K0.00%+4,127New
JPMorgan Chase & Co1,679$1.08K0.00%+1,679New
GAMMA Investing LLC1,225$7900.00%+1,225New
Rhumbline Advisers1,164$7490.00%+1,081+1,302.4%Added
Harbour Investments, Inc.236$1520.00%00.0%Unchanged
New England Capital Financial Advisors LLC201$1300.00%00.0%Unchanged
Truvestments Capital LLC200$1290.00%+200New
Wells Fargo & Company140$900.00%+135+2,700.0%Added
Toth Financial Advisory Corp30$200.00%+30New
FNY Investment Advisers, LLC0$00.00%−8,200−100.0%Sold out
Signaturefd, LLC0$00.00%−492−100.0%Sold out
Morgan Stanley0$00.00%−90−100.0%Sold out
Sanctuary Wealth Management, L.L.C.0$00.00%−12−100.0%Sold out